Sean P. Brusky

Corporate Officer/Principal at PARDES BIOSCIENCES, INC.

47 year

Health Technology

Consumer Services

Profile

Sean P.
Brusky is currently the Chief Commercial Officer at Pardes Biosciences, Inc. He previously worked as the Head of Healthcare Delivery Innovation at Genentech, Inc. and as a Manager of Business and Corporate Development at Vertex Pharmaceuticals, Inc. He received his undergraduate degree from Brown University and his MBA from Harvard Business School.

Sean P. Brusky active positions

Companies	Position	Start
PARDES BIOSCIENCES, INC.	Corporate Officer/Principal	01/05/2021

All active positions of Sean P. Brusky

Former positions of Sean P. Brusky

Companies	Position	End
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	01/08/2004
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	-

See the detail of Sean P. Brusky's experience

Training of Sean P. Brusky

Brown University	Undergraduate Degree
Harvard Business School	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sean P. Brusky's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology

Private companies	2
Pardes Biosciences, Inc. Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA.	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology